Primary and secondary prevention of cerebral ischemia: joint guidelines of the German Society of Neurology (DGN) and German Stroke Society (DSG)
Classification of level of evidence: ↑↑ Efficacy and usefulness is well supported by multiple appropriate clinical studies (i.e. controlled randomized trials), either one or more metaanalyses or systematic reviews. ↑Efficacy and usefulness is supported by at least one appropriate clinical study (i.e...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
21. Mai 2010
|
| In: |
Aktuelle Neurologie
Year: 2010, Volume: 37, Issue: 4, Pages: e2-e22 |
| ISSN: | 1438-9428 |
| DOI: | 10.1055/s-0029-1223537 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0029-1223537 Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1223537 |
| Author Notes: | H.-C. Diener, F. Aichner, C. Bode, M. Böhm, H.-H. Eckstein, K. Einhäupl, M. Endres, F. Forsting, S. Gesenhues, M. Grond, R.L. Haberl, W. Hacke, M. Hennerici, P. Lyrer, A. Link, B. Ringelstein, P.A. Ringleb, J. Schrader, C. Weimar |
| Summary: | Classification of level of evidence: ↑↑ Efficacy and usefulness is well supported by multiple appropriate clinical studies (i.e. controlled randomized trials), either one or more metaanalyses or systematic reviews. ↑Efficacy and usefulness is supported by at least one appropriate clinical study (i.e. controlled randomized trial). ↓↓ Lack of efficacy is well supported by one or more appropriate clinical studies (i.e. controlled randomized trial), either one or more metaanalyses or systematic reviews. ↔ No study results exist to prove any benefit or harm. This can be due lack of appropriate studies, or several studies with controversial results. |
|---|---|
| Item Description: | Gesehen am 02.02.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1438-9428 |
| DOI: | 10.1055/s-0029-1223537 |